Baker Bros. Advisors’s Aligos Therapeutics ALGS Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$617K	Hold	83,055	–	–	﹤0.01%	82
2025 Q4	$774K	Hold	83,055	–	–	﹤0.01%	83
2025 Q3	$814K	Hold	83,055	–	–	0.01%	86
2025 Q2	$599K	Hold	83,055	–	–	0.01%	85
2025 Q1	$685K	Hold	83,055	–	–	0.01%	83
2024 Q4	$3.31M	Hold	83,055	–	–	0.04%	78
2024 Q3	$719K	Sell	83,055 -1	-0%	-$12	0.01%	87
2024 Q2	$727K	Hold	83,056	–	–	0.01%	89
2024 Q1	$2.03M	Hold	83,056	–	–	0.03%	74
2023 Q4	$1.38M	Hold	83,056	–	–	0.02%	74
2023 Q3	$1.55M	Hold	83,056	–	–	0.01%	92
2023 Q2	$2.02M	Hold	83,056	–	–	0.01%	94
2023 Q1	$1.81M	Hold	83,056	–	–	0.01%	93
2022 Q4	$1.98M	Hold	83,056	–	–	0.01%	98
2022 Q3	$2.28M	Hold	83,056	–	–	0.02%	99
2022 Q2	$2.51M	Hold	83,056	–	–	0.01%	92
2022 Q1	$4.46M	Hold	83,056	–	–	0.03%	87
2021 Q4	$24.6M	Hold	83,056	–	–	0.12%	51
2021 Q3	$32.2M	Buy	83,056 +18,656	+29%	+$7.38M	0.14%	49
2021 Q2	$32.8M	Hold	64,400	–	–	0.14%	51
2021 Q1	$36.6M	Hold	64,400	–	–	0.16%	51
2020 Q4	$44.5M	Buy	+64,400	New	+$31.4M	0.17%	37

Other funds holding ALGS